BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 27181894)

  • 1. [Comparison of the Predictive Values of Eight Staging Systems for Primary Liver Cancer in Prognosis of Combined Hepatocellular-cholangiocellular Carcinoma Patients after Surgery].
    Li H; Wang XT; Zhang AQ; Meng XF; Yu Q; Lü WP; Duan WD; Dong JH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Apr; 38(2):175-81. PubMed ID: 27181894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Predictive Value of Staging Systems and Inflammation Scores for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgical Resection: a Retrospective Study.
    He C; Mao Y; Wang J; Song Y; Huang X; Lin X; Li S
    J Gastrointest Surg; 2018 Jul; 22(7):1239-1250. PubMed ID: 29667093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?
    Zhou Q; Cai H; Xu MH; Ye Y; Li XL; Shi GM; Huang C; Zhu XD; Cai JB; Zhou J; Fan J; Ji Y; Sun HC; Shen YH
    Hepatobiliary Pancreat Dis Int; 2021 Feb; 20(1):13-20. PubMed ID: 33160852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy.
    Chen TW; Chu CM; Yu JC; Chen CJ; Chan DC; Liu YC; Hsieh CB
    Eur J Surg Oncol; 2007 May; 33(4):480-7. PubMed ID: 17129701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
    Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
    J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and ranking of seven staging systems of hepatocellular carcinoma.
    Chen ZH; Hong YF; Lin J; Li X; Wu DH; Wen JY; Chen J; Ruan DY; Lin Q; Dong M; Wei L; Wang TT; Lin ZX; Ma XK; Wu XY; Xu R
    Oncol Lett; 2017 Jul; 14(1):705-714. PubMed ID: 28693224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI.
    Lu W; Dong J; Huang Z; Guo D; Liu Y; Shi S
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1874-8. PubMed ID: 18752560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
    Kudo M; Chung H; Osaki Y
    J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluations of seven different clinical staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection].
    Zhao J; Yan T; Huang Z; Bi X; Zhao H; Zhou J; Li Z; Li Y; Li C; Cai J
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):903-7. PubMed ID: 24854909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma.
    Kim SH; Park YN; Lim JH; Choi GH; Choi JS; Kim KS
    Eur J Surg Oncol; 2014 Aug; 40(8):976-81. PubMed ID: 24909336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery.
    Lee SD; Park SJ; Han SS; Kim SH; Kim YK; Lee SA; Ko YH; Hong EK
    Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):594-601. PubMed ID: 25475861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review.
    Gupta R; Togashi J; Akamatsu N; Sakamoto Y; Kokudo N
    Surg Today; 2017 Aug; 47(8):908-917. PubMed ID: 28124125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.
    Zhang JF; Shu ZJ; Xie CY; Li Q; Jin XH; Gu W; Jiang FJ; Ling CQ
    PLoS One; 2014; 9(3):e88182. PubMed ID: 24609114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
    Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
    J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
    Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems.
    Zhang XF; Qi X; Meng B; Liu C; Yu L; Wang B; Lv Y
    Eur J Surg Oncol; 2010 Aug; 36(8):718-24. PubMed ID: 20538423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
    Huo TI; Hsia CY; Huang YH; Lin HC; Lee PC; Lui WY; Chiang JH; Chiou YY; Loong CC; Lee SD
    J Clin Gastroenterol; 2009 Sep; 43(8):773-81. PubMed ID: 19262404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy.
    Seong J; Shim SJ; Lee IJ; Han KH; Chon CY; Ahn SH
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1037-42. PubMed ID: 17234356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.